BG Medicine To Conduct Joint Biomarker Discovery Study For Muscle Toxicity With Mitsubishi Pharma Corporation

Published: Mar 27, 2006

WALTHAM, Mass.--(BUSINESS WIRE)--March 28, 2006--BG Medicine Inc. today announced a collaborative preclinical research study into the biochemical origins of muscle toxicity and associated biomarkers with Mitsubishi Pharma Corporation (Osaka, Japan).

Back to news